In accordance with this, Wesley and colleagues demonstrated that PTX3 promotes tumor growth, angiogenesis, and invasiveness by upregulating VEGF and IL-8 through NF-κB activation, hypothesizing that PTX3 overexpression contributes to GB progression through altered expression of downstream targets involved in angiogenesis, invasion, and migration processes [66]. The gene discussed is PTX3; the disease is neoplasm.